On October 11, hosted by the People’s Daily Health Client, the “Expert–Media Roundtable on the Scientific Application of Hydrogen-Oxygen Medicine” was held in Beijing. Experts and scholars from multiple fields—including healthcare, scientific research, industry, and media—gathered to jointly discuss the applications and prospects of hydrogen-oxygen medicine in modern healthcare.
Vice President of the Beijing Medical Association Li Ning
Li Ning, Vice President of the Beijing Medical Association and former President of Beijing You’an Hospital, stated that the application of hydrogen-oxygen medicine during the COVID-19 pandemic attracted widespread attention. Hydrogen molecules, due to their small molecular weight and strong cellular penetration capability, can counteract oxidative stress and inflammation, reduce the release of inflammatory cytokines, and promote cellular repair and structural stability. In the treatment of COVID-19, hydrogen-oxygen therapy demonstrated positive effects in reducing the incidence of severe cases and lowering long-term adverse outcomes, providing new therapeutic perspectives for the medical community; its potential applications in other disease areas also merit further exploration.
Secretary-General Cheng Youqin, Hydrogen Molecular Biomedicine Branch, China Association of Gerontology and Geriatrics
Cheng Youqin, Secretary-General of the Hydrogen Molecular Biomedicine Branch of the China Association of Gerontology and Geriatrics and former Deputy Director of the First Department of Cardiovascular Medicine, Clinical Division, South Building of the Chinese PLA General Hospital, noted that hydrogen gas has drawn attention for its selective antioxidant effects. Since 2017, a large number of research papers—including animal experiments and clinical studies—have investigated the mechanisms of action and clinical effects of hydrogen gas and hydrogen-oxygen mixed gas. In 2020, the National Medical Products Administration approved hydrogen-oxygen inhalation devices as Class III medical devices, and hydrogen gas and hydrogen-oxygen inhalation are expected to become adjunctive approaches for the prevention and management of chronic diseases.
Director of the Department of Critical Care Medicine, Tianjin Medical University General Hospital Xie Keliang
Xie Keliang, Director of the Department of Critical Care Medicine at Tianjin Medical University General Hospital and Deputy Director of the Tianjin Institute of Anesthesiology, explained: “In 2007, I began studying the selective antioxidant effects of hydrogen gas and exploring its organ-protective properties. Our research progressed from animal studies to clinical trials, involving cardiac surgery, pneumonia surgery, and critically ill patients in the ICU (intensive care unit). After approximately 15 years, we found that hydrogen gas not only exhibits selective antioxidant activity, but also activates endogenous antioxidant and protective systems. In clinical practice, hydrogen-oxygen mixed gas has been used to treat multiple diseases, including respiratory failure, COVID-19, and neuropathic pain, helping to prevent disease progression from mild to severe or even critical stages.”
Lv Youyong, Peking University Cancer Hospital
Lv Youyong, Professor at Peking University Cancer Hospital and the Molecular Oncology Research Division of the Beijing Institute for Cancer Research, stated that the goal of cancer prevention and treatment lies in reducing incidence and improving therapeutic effectiveness. Hydrogen gas, due to its unique physicochemical properties, is considered an effective antioxidant and may play a role in cancer prevention and management. Hydrogen also has anti-inflammatory effects and may help mitigate the toxic side effects of radiotherapy and chemotherapy in tumor treatment, as these adverse reactions are often associated with inflammation. In addition, in tissue repair and regeneration, hydrogen may be used in combination with immune cells to enhance therapeutic outcomes.
Editor: Ma Jiayue
